NCT05535413 2025-04-25UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain MetastasesHunan Cancer HospitalPhase 1/2 Recruiting30 enrolled
NCT01132664 2016-08-17Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast CancerNovartisPhase 1/2 Terminated72 enrolled 15 charts